Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1876
CALL
Clorox
CLX
$13.3B
| $4.43M | ﹤0.01% |
54,700
-3,400
| -6% | -$327K |
2025 Q2
5 quarters
|
|
1877
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
| $4.43M | ﹤0.01% |
+194,006
| New | +$4.71M |
2026 Q3
0 quarters
|
|
1878
Enphase Energy
ENPH
$3.45B
| $4.43M | ﹤0.01% |
+134,139
| New | +$5.17M |
2026 Q3
0 quarters
|
|
1879
Monte Rosa Therapeutics
GLUE
$801M
| $4.42M | ﹤0.01% |
+370,246
| New | +$6.35M |
2026 Q3
0 quarters
|
|
1880
Janus International
JBI
$467M
| $4.41M | ﹤0.01% |
1,079,278
-1,164,645
| -52% | -$5.81M |
2026 Q2
1 quarter
|
|
1881
CALL
General Motors
GM
$72.5B
| $4.41M | ﹤0.01% |
57,300
-35,100
| -38% | -$2.94M |
2023 Q4
11 quarters
|
|
1882
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$6.89B
| $4.41M | ﹤0.01% |
83,599
+18,244
| +28% | +$979K |
2026 Q2
1 quarter
|
|
1883
Oculis Holding
OCS
$426M
| $4.4M | ﹤0.01% |
470,647
+208,534
| +80% | +$2.48M |
2026 Q1
2 quarters
|
|
1884
Taysha Gene Therapies
TSHA
$1.34B
| $4.39M | ﹤0.01% |
901,863
+642,258
| +247% | +$3.7M |
2026 Q2
1 quarter
|
|
1885
STRATTEC Security
STRT
$250M
| $4.39M | ﹤0.01% |
67,593
+35,270
| +109% | +$2.74M |
2025 Q3
4 quarters
|
|
1886
Turkcell
TKC
$4.19B
| $4.38M | ﹤0.01% |
886,443
-173,224
| -16% | -$941K |
2024 Q1
10 quarters
|
|
1887
PUT
Domino's
DPZ
$11.2B
| $4.37M | ﹤0.01% |
14,600
-2,200
| -13% | -$721K |
2025 Q2
5 quarters
|
|
1888
First Community Corp
FCCO
$307M
| $4.37M | ﹤0.01% |
135,934
-19,602
| -13% | -$657K |
2025 Q4
3 quarters
|
|
1889
Navan Inc
NAVN
$6.62B
| $4.37M | ﹤0.01% |
208,305
+127,018
| +156% | +$3.27M |
2026 Q2
1 quarter
|
|
1890
VanEck Junior Gold Miners ETF
GDXJ
$7.29B
| $4.36M | ﹤0.01% |
38,277
-79,557
| -68% | -$9.04M |
2025 Q2
5 quarters
|
|
1891
TPG RE Finance Trust
TRTX
$491M
| $4.35M | ﹤0.01% |
694,476
-589,912
| -46% | -$4.64M |
2024 Q2
9 quarters
|
|
1892
ChipMOS TECHNOLOGIES
IMOS
$1.71B
| $4.35M | ﹤0.01% |
60,551
+27,910
| +86% | +$1.66M |
2026 Q2
1 quarter
|
|
1893
Compass Therapeutics
CMPX
$139M
| $4.34M | ﹤0.01% |
4,170,894
+483,405
| +13% | +$996K |
2025 Q4
3 quarters
|
|
1894
Kyndryl
KD
$3.66B
| $4.33M | ﹤0.01% |
384,235
-20,576
| -5% | -$261K |
2026 Q2
1 quarter
|
|
1895
Gildan
GIL
$6.42B
| $4.32M | ﹤0.01% |
101,348
+97,067
| +2,267% | +$5.02M |
2024 Q4
7 quarters
|
|
1896
Mine Safety
MSA
$6.71B
| $4.32M | ﹤0.01% |
+24,275
| New | +$4.41M |
2026 Q3
0 quarters
|
|
1897
Sensient Technologies
SXT
$4.97B
| $4.32M | ﹤0.01% |
+33,014
| New | +$4.19M |
2026 Q3
0 quarters
|
|
1898
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$38.9B
| $4.3M | ﹤0.01% |
70,313
-148,674
| -68% | -$9.3M |
2022 Q1
18 quarters
|
|
1899
BayCom
BCML
$339M
| $4.27M | ﹤0.01% |
140,785
+42,573
| +43% | +$1.33M |
2026 Q2
1 quarter
|
|
1900
Cimpress
CMPR
$1.41B
| $4.27M | ﹤0.01% |
+55,337
| New | +$5.08M |
2026 Q3
0 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.